CRISPR May Consider IPO
Rodger Novak, Chief Executive Officer of CRISPR Therapeutics AG said, ” Crispr Therapeutics would consider an IPO in 2016.
Latest
Archives
- January 2021
- January 2020
- November 2019
- September 2019
- August 2019
- August 2018
- April 2018
- February 2018
- November 2016
- October 2016
- September 2016
- August 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015